- Home
- RXRX vs SHOO Comparison
RXRX vs SHOO Comparison
Compare RXRX & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- SHOO
- Stock Information
- Founded
- RXRX 2013
- SHOO 1990
- Country
- RXRX United States
- SHOO United States
- Employees
- RXRX N/A
- SHOO N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- SHOO Shoe Manufacturing
- Sector
- RXRX Health Care
- SHOO Consumer Discretionary
- Exchange
- RXRX Nasdaq
- SHOO Nasdaq
- Market Cap
- RXRX 2.0B
- SHOO 1.7B
- IPO Year
- RXRX 2021
- SHOO 1993
- Fundamental
- Price
- RXRX $5.25
- SHOO $25.98
- Analyst Decision
- RXRX Buy
- SHOO Hold
- Analyst Count
- RXRX 5
- SHOO 6
- Target Price
- RXRX $7.00
- SHOO $26.00
- AVG Volume (30 Days)
- RXRX 32.1M
- SHOO 1.5M
- Earning Date
- RXRX 08-07-2025
- SHOO 07-30-2025
- Dividend Yield
- RXRX N/A
- SHOO 3.23%
- EPS Growth
- RXRX N/A
- SHOO N/A
- EPS
- RXRX N/A
- SHOO 2.32
- Revenue
- RXRX $59,790,000.00
- SHOO $2,284,080,000.00
- Revenue This Year
- RXRX $23.51
- SHOO $12.44
- Revenue Next Year
- RXRX $53.87
- SHOO $8.22
- P/E Ratio
- RXRX N/A
- SHOO $11.20
- Revenue Growth
- RXRX 29.32
- SHOO 10.34
- 52 Week Low
- RXRX $3.79
- SHOO $19.05
- 52 Week High
- RXRX $12.36
- SHOO $50.01
- Technical
- Relative Strength Index (RSI)
- RXRX 55.15
- SHOO 59.17
- Support Level
- RXRX $4.91
- SHOO $23.67
- Resistance Level
- RXRX $5.44
- SHOO $24.27
- Average True Range (ATR)
- RXRX 0.36
- SHOO 0.95
- MACD
- RXRX 0.01
- SHOO 0.23
- Stochastic Oscillator
- RXRX 72.37
- SHOO 90.03
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.